Starling Registry Study

Baxter

Status: Completed

Conditions: Hemodynamic Monitoring

Treatments: Device: Starling

Study type: Observational

Funder types: Industry

Identifiers

NCT04648293

BXU553561

Details and patient eligibility

About

Hemodynamic optimization of critically ill patients is a goal for clinicians in order to afford the patient the best possible outcomes. Being able to precisely and rapidly determine patient fluid responsiveness provides the bedside physician and nursing staff the information needed to make critical decisions in regards to the patient's fluid status and management of additional fluids and medications.

As fluid management and cardiac output determination are linked to better decision-making and improved outcomes in ICU, the use of a dynamic assessment of fluid responsiveness becomes a key tool for patient management.

This study is designed to collect treatment and outcome data on patients that have undergone hemodynamic monitoring in a wide variety of clinical settings, involving a variety of patient diagnoses.

Enrollment: 1,207 patients

Sex: All

Ages: 18 to 95 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ≥18 to 95 years of age
• Patient has undergone hemodynamic monitoring with the Starling monitor
• Hemodynamic monitoring was completed no earlier than 2018

Exclusion criteria

• None

Trial design

1,207 participants in 2 patient groups

Improvement in Hemodynamics

Description:

Over the course of a patient's hospitalization, data will be collected on patients from the initiation to completion of hemodynamic monitoring with the Starling monitor in a wide variety of clinical settings, and for different diagnoses. Improvement in hemodynamics is exhibited by an increase in both Cardiac Output and Stroke Volume observed at 12 hour intervals from time of monitoring until completion.

Treatment:

Device: Starling

No Improvement in Hemodynamics

Description:

Over the course of a patient's hospitalization, data will be collected on patients from the initiation to completion of hemodynamic monitoring with the Starling monitor in a wide variety of clinical settings, and for different diagnoses. No Improvement in hemodynamics is exhibited by no increase in both Cardiac Output and Stroke Volume observed at 12 hour intervals from time of monitoring until completion.

Treatment:

Device: Starling